Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

48° Sunny
- Saint Marys, OH (45885)
  Today
  
  A mix of clouds and sun. High around 50F. Winds W at 5 to 10 mph..
  
  Tonight
  
  Cloudy skies. Low 27F. Winds NW at 5 to 10 mph.
  
  Updated: February 10, 2026 @ 2:45 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Insmed Incorporated - Common Stock (NQ:INSM)

149.31 -0.22 (-0.15%)

Streaming Delayed Price Updated: 3:33 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

January 20, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

January 13, 2026

From Pomerantz LLP

Via GlobeNewswire

Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗

January 06, 2026

Investors today are cheering envudeucitinib's Phase 3 edge in oral TYK2 psoriasis as well as Alumis' plans to raise fresh capital.

Via The Motley Fool

Topics Stocks

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

A Preview Of Insmed's Earnings ↗

October 29, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm

December 29, 2025

From The Schall Law Firm

Via Business Wire

Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗

December 28, 2025

Selling shares usually signals doubt, but in this case the math points to something very different happening beneath the surface.

Via The Motley Fool

Topics Regulatory Compliance

Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗

December 17, 2025

While the drug was well tolerated with no new safety concerns, the drug yielded no positive treatment benefits in a study even at its highest dose of 40 mg.

Via Stocktwits

Wondering what's happening in today's after-hours session? ↗

December 17, 2025

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

One specialist investor just walked away from STAAR Surgical entirely—right as uncertainty over a delayed Alcon deal looms.

Via The Motley Fool

Topics Regulatory Compliance

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

PTC’s turnaround quarter is raising eyebrows—here’s why one major investor just doubled down.

Via The Motley Fool

Topics Regulatory Compliance

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares?

Via The Motley Fool

Topics Regulatory Compliance

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an...

Via MarketMinute

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗

November 30, 2025

Stanley Druckenmiller is considered one of the greatest investors of all time.

Via The Motley Fool

Topics Artificial Intelligence

Billionaire Stanley Druckenmiller Just Bet Big on This Hot IPO Stock. Is It a Buy? ↗

November 23, 2025

This online ticket marketplace debuted in September, but has struggled thus far.

Via The Motley Fool

Topics ETFs Initial Public Offering Regulatory Compliance

Peering Into Insmed Inc's Recent Short Interest ↗

November 18, 2025

Via Benzinga

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation.

Via Benzinga

If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today ↗

November 14, 2025

Via Benzinga

This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash ↗

November 10, 2025

This Investor Sold $1.9 Million in AMSC Stock Ahead of 35% Post-Earnings Crash

Via The Motley Fool

Topics Regulatory Compliance

Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High ↗

November 09, 2025

Essex Investment Buys $7.1 Million Globalstar Stake as Revenue Hits Record High

Via The Motley Fool

Topics Regulatory Compliance

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 31, 2025

Via Benzinga

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗

October 30, 2025

Via Benzinga

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Via Benzinga

Topics Economy

Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports ↗

October 30, 2025

Insmed stock surged early Thursday as Argenx stock rose more moderately. The top-notch biotech companies beat third-quarter calls.

Via Investor's Business Daily

Here's How Much $1000 Invested In Insmed 5 Years Ago Would Be Worth Today ↗

October 23, 2025

Via Benzinga

This Is What Whales Are Betting On Insmed ↗

October 15, 2025

Via Benzinga

Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today ↗

October 07, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Business
Announcements
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Evening Leader

theeveningleader.com
102 E. Spring St.
Saint Marys, Ohio 45885
Phone: 419-394-7414
Email: editor@theeveningleader.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Saint Marys, OH (45885)

Today

Tonight

Insmed Incorporated - Common Stock (NQ:INSM)

All News about Insmed Incorporated - Common Stock

Sections

Services

The Evening Leader